Multi-parametric evaluation of chronic kidney disease by MRI: A preliminary cross-sectional study

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Prasad, Pottumarthi V ^a   Thacker, Jon ^b   Li, Lu Ping ^a   Haque, Muhammad ^a   Li, Wei ^a   Koenigs, Heather ^a   Zhou, Ying ^a   Sprague, Stuart M ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b Northwestern University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE;

ADULT; ARTICLE; BOLD SIGNAL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIFFUSION WEIGHTED IMAGING; FEASIBILITY STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPOXIA; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PARENCHYMA; KIDNEY VOLUME; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; PATHOLOGY;

CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84947229182     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139661     Document Type: Article

References (41)

1. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266. PMID: 11904577
2. Zhang QL, Rothenbacher D (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 8: 117. doi: 10.1186/1471-2458-8-117 PMID: 18405348
3. Khan S, Amedia CA Jr (2008) Economic burden of chronic kidney disease. J Eval Clin Pract 14: 422-434. doi: 10.1111/j.1365-2753.2007.00883.x PMID: 18373575
4. Devarajan P (2010) The use of targeted biomarkers for chronic kidney disease. Adv Chronic Kidney Dis 17: 469-479. doi: 10.1053/j.ackd.2010.09.002 PMID: 21044769
5. Tonelli M, Manns B (2011) Supplementing creatinine-based estimates of risk in chronic kidney disease: is it time? JAMA 305: 1593-1595. doi: 10.1001/jama.2011.502 PMID: 21482745
6. Temple R (2010) Enrichment of clinical study populations. Clin Pharmacol Ther 88: 774-778. doi: 10.1038/clpt.2010.233 PMID: 20944560
7. Fine LG, Norman JT (2008) Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 74: 867-872. doi: 10.1038/ki.2008.350 PMID: 18633339
8. Bernhardt WM, Warnecke C, Willam C, Tanaka T, Wiesener MS, Eckardt KU (2007) Organ protection by hypoxia and hypoxia-inducible factors. Methods Enzymol 435: 221-245. PMID: 17998057
9. Rosenberger C, Pratschke J, Rudolph B, Heyman SN, Schindler R, Babel N, et al. (2007) Immunohistochemical detection of hypoxia-inducible factor-1alpha in human renal allograft biopsies. J Am Soc Nephrol 18: 343-351. PMID: 17182883
10. Thoeny HC, De Keyzer F, Oyen RH, Peeters RR (2005) Diffusion-weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: initial experience. Radiology 235: 911-917. PMID: 15845792
11. Togao O, Doi S, Kuro-o M, Masaki T, Yorioka N, TakahashiM (2010) Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstruction. Radiology 255: 772-780. doi: 10.1148/radiol.10091735 PMID: 20406881
12. Lucisano G, Comi N, Pelagi E, Cianfrone P, Fuiano L, Fuiano G (2015) Can renal sonography be a reliable diagnostic tool in the assessment of chronic kidney disease? J Ultrasound Med 34: 299-306. doi: 10.7863/ultra.34.2.299 PMID: 25614403
13. Epstein FH (1997) Oxygen and renal metabolism. Kidney Int 51: 381-385. PMID: 9027710
14. Cheong B, Muthupillai R, Rubin MF, Flamm SD (2007) Normal values for renal length and volume as measured by magnetic resonance imaging. Clin J Am Soc Nephrol 2: 38-45. PMID: 17699385
15. Sullivan GM, Feinn R (2012) Using Effect Size-or Why the P Value Is Not Enough. J Grad Med Educ 4: 279-282. doi: 10.4300/JGME-D-12-00156.1 PMID: 23997866
16. Harman A, Chang KJ, Dupuy D, Rintels P (2014) The long-lasting effect of ferumoxytol on abdominal magnetic resonance imaging. J Comput Assist Tomogr 38: 571-573. doi: 10.1097/RCT. 0000000000000086 PMID: 24733001
17. Epstein FH, Prasad P (2000) Effects of furosemide on medullary oxygenation in younger and older subjects. Kidney international 57: 2080-2083. PMID: 10792627
18. Pruijm M, Hofmann L, Piskunowicz M, Muller ME, Zweiacker C, Bassi I, et al. (2014) Determinants of renal tissue oxygenation as measured with BOLD-MRI in chronic kidney disease and hypertension in humans. PLoS One 9: e95895. doi: 10.1371/journal.pone.0095895 PMID: 24760031
19. Inoue T, Kozawa E, Okada H, Inukai K, Watanabe S, Kikuta T, et al. (2011) Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J Am Soc Nephrol 22: 1429-1434. doi: 10.1681/ASN.2010111143 PMID: 21757771
20. Michaely HJ, Metzger L, Haneder S, Hansmann J, Schoenberg SO, Attenberger UI (2012) Renal BOLD-MRI does not reflect renal function in chronic kidney disease. Kidney Int 81: 684-689. doi: 10.1038/ki.2011.455 PMID: 22237750
21. Pruijm M, Hofmann L, Zanchi A, Maillard M, Forni V, Muller ME, et al. (2013) Blockade of the reninangiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes. Diabetes Res Clin Pract 99: 136-144. doi: 10.1016/j.diabres.2012.11.004 PMID: 23245807
22. Wang ZJ, Kumar R, Banerjee S, Hsu CY (2011) Blood oxygen level-dependent (BOLD) MRI of diabetic nephropathy: preliminary experience. J Magn Reson Imaging 33: 655-660. doi: 10.1002/jmri.22501 PMID: 21563249
23. Xin-Long P, Jing-Xia X, Jian-Yu L, Song W, Xin-Kui T (2012) A preliminary study of blood-oxygen-leveldependent MRI in patients with chronic kidney disease. Magn Reson Imaging 30: 330-335. doi: 10.1016/j.mri.2011.10.003 PMID: 22244540
24. Yin WJ, Liu F, Li XM, Yang L, Zhao S, Huang ZX, et al. (2012) Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI. Eur J Radiol 81: 1426-1431. doi: 10.1016/j.ejrad.2011. 03.045 PMID: 21470811
25. Fine LG, Dharmakumar R (2012) Limitations of BOLD-MRI for assessment of hypoxia in chronically diseased human kidneys. Kidney Int 82: 934-935; author reply 935. doi: 10.1038/ki.2012.283 PMID: 23018828
26. Inoue T, Kozawa E, Okada H, Suzuki H (2012) Is there no future for renal BOLD-MRI? Kidney Int 82: 934; author reply 935. doi: 10.1038/ki.2012.282 PMID: 23018827
27. Neugarten J (2012) Renal BOLD-MRI and assessment for renal hypoxia. Kidney Int 81: 613-614. doi: 10.1038/ki.2011.462 PMID: 22419042
28. Milani B, Piskunowicz M, Bassi I, Anex C, Vogt B, Stuber M, et al. Radial R2∗ distribution: a new method to analyze BOLD MRI of kidneys; 2015; Toronto, CA. pp. 466.
29. Thacker JM, Li LP, Li W, Zhou Y, Sprague SM, Prasad PV (2015) Renal Blood Oxygenation Level-Dependent Magnetic Resonance Imaging: A Sensitive and Objective Analysis. Invest Radiol.
30. Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, et al. (2012) Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis 59: 504-512. doi: 10.1053/j.ajkd.2011.12.009 PMID: 22284441
31. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, et al. (2009) Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 4: 337-344. doi: 10.2215/CJN.03530708 PMID: 19176795
32. Lin W, Paczynski RP, Celik A, Hsu CY, Powers WJ (1998) Effects of acute normovolemic hemodilution on T2∗-weighted images of rat brain. Magn Reson Med 40: 857-864. PMID: 9840830
33. Brezis M, Agmon Y, Epstein FH (1994) Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol 267: F1059-1062. PMID: 7810692
34. Manotham K, Ongvilawan B, Urusopone P, Chetsurakarn S, Tanamai J, Limkuansuwan P, et al. (2012) Angiotensin II receptor blocker partially ameliorated intrarenal hypoxia in chronic kidney disease patients: a pre-/post-study. Intern Med J 42: e33-37. PMID: 22611567
35. Siddiqi L, Hoogduin H, Visser F, Leiner T, Mali WP, Blankestijn PJ (2014) Inhibition of the renin-angiotensin system affects kidney tissue oxygenation evaluated by magnetic resonance imaging in patients with chronic kidney disease. J Clin Hypertens (Greenwich) 16: 214-218.
36. Li Q, Li J, Zhang L, Chen Y, Zhang M, Yan F (2014) Diffusion-weighted imaging in assessing renal pathology of chronic kidney disease: A preliminary clinical study. Eur J Radiol 83: 756-762. doi: 10.1016/j.ejrad.2014.01.024 PMID: 24581595
37. Xu X, Fang W, Ling H, Chai W, Chen K (2010) Diffusion-weighted MR imaging of kidneys in patients with chronic kidney disease: initial study. Eur Radiol 20: 978-983. doi: 10.1007/s00330-009-1619-8 PMID: 19789876
38. Zhao J, Wang ZJ, Liu M, Zhu J, Zhang X, Zhang T, et al. (2014) Assessment of renal fibrosis in chronic kidney disease using diffusion-weighted MRI. Clin Radiol 69: 1117-1122. doi: 10.1016/j.crad.2014.06. 011 PMID: 25062924
39. Storey P, Ji L, Li LP, Prasad PV (2011) Sensitivity of USPIO-enhanced R2 imaging to dynamic blood volume changes in the rat kidney. Journal of Magnetic Resonance Imaging 33: 1091-1099. doi: 10.1002/jmri.22526 PMID: 21509866
40. Chandarana H, Lee VS, Hecht E, Taouli B, Sigmund EE (2011) Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Invest Radiol 46: 285-291. doi: 10.1097/RLI.0b013e3181ffc485 PMID: 21102345
41. Tan H, Koktzoglou I, Prasad PV (2014) Renal perfusion imaging with two-dimensional navigator gated arterial spin labeling. Magn Reson Med 71: 570-579. doi: 10.1002/mrm.24692 PMID: 23447145